Hemogenyx Pharmaceuticals Plc Stock Filter Stocks by Fundamentals
| HOPHF Stock | USD 0 0.00 0.00% |
Hemogenyx Pharmaceuticals Plc fundamentals help investors to digest information that contributes to Hemogenyx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hemogenyx Pink Sheet. The fundamental analysis module provides a way to measure Hemogenyx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemogenyx Pharmaceuticals pink sheet.
Hemogenyx |
Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Hemogenyx Fundamentals
| Return On Equity | -0.32 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 8.17 M | |||
| Shares Outstanding | 1.14 B | |||
| Shares Owned By Insiders | 13.01 % | |||
| Price To Book | 1.78 X | |||
| EBITDA | (2.39 M) | |||
| Net Income | (5.1 M) | |||
| Cash And Equivalents | 6.84 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 10.15 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 20.23 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (2.63 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 10 | |||
| Beta | 3.49 | |||
| Market Capitalization | 45.68 M | |||
| Total Asset | 8.52 M | |||
| Net Asset | 8.52 M |
About Hemogenyx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemogenyx Pharmaceuticals Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Hemogenyx Pink Sheet
Hemogenyx Pharmaceuticals financial ratios help investors to determine whether Hemogenyx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemogenyx with respect to the benefits of owning Hemogenyx Pharmaceuticals security.